COVID-19 Drug Made in Austria

PeopleEntrepreneurs ♦ Published: May 19, 2020; 19:40 ♦ (Vindobona)

Austrian biotech company Apeiron Biologics AG, which is currently working on a drug to treat the coronavirus, announces financing round for the further development of the COVID-19 drug APN01.

APN01 Mode of Action / Picture: © APEIRON BIOLOGICS AG

Apeiron Biologics AG will complete a capital increase to finance the further development of APN01 for the treatment of severely ill COVID-19 patients as well as the development of immuno-oncology projects. …